CircRNAs modulate response of cancer cells to gemcitabine
As a chemotherapeutic agent, gemcitabine makes the backbone of several chemotherapeutic regimens, particularly those used for advanced cancers. However, drug resistance confines the long-term therapeutic impact of gemcitabine in cancer treatment and makes the patients' prognosis poor. Several m...
Saved in:
| Main Authors: | Zahra Tajik, Soudeh Ghafouri-Fard |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-12-01
|
| Series: | Advances in Cancer Biology - Metastasis |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2667394025000115 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The role of circRNAs in resistance to doxorubicin
by: Mahla Sanati, et al.
Published: (2024-11-01) -
HNRNPD regulates the biogenesis of circRNAs and the ratio of mRNAs to circRNAs for a set of genes
by: Shuhui Chang, et al.
Published: (2024-12-01) -
Comprehensive analysis of the circRNA expression profile and circRNA-miRNA-mRNA network in pelvic organ prolapse
by: Qian Wang, et al.
Published: (2025-01-01) -
The role of circRNA in breast cancer drug resistance
by: Shaofeng Yang, et al.
Published: (2024-12-01) -
Mesangial cell-derived CircRNAs in chronic glomerulonephritis: RNA sequencing and bioinformatics analysis
by: Ji Hui Fan, et al.
Published: (2024-12-01)